Did the tests treat people like you?
What have the TB-500 studies actually established?
The lab-made substance is linked to how cells move. You’ll read what happened in wound, muscle, heart, and brain tests. Most experiments treated animals with the larger natural protein.
What did the lab test show inside a cell?
TB-500 has a section from thymosin beta-4 holding actin, the protein used by cells to maintain their shape [6]. You’ll read what TB-500 does in a lab, followed by the animal healing experiments. To reach damaged tissue, cells need to reshape themselves. That movement alone doesn’t show whether your injury heals sooner.
This experiment examined proteins, without treating anyone’s injury. Researchers found thymosin beta-4 joined with actin 1:1, meaning each pair has one protein of each kind [6]. Some actin remains available for reshaping cells because the protein is held apart. A cell that changes shape can move toward damage.
X-rays showed how thymosin beta-4 held actin, down to 2 angstroms, a unit for tiny lengths. That number describes the detail the X-rays could show. Seeing how two proteins fit together helps explain cell movement, but the experiment didn’t treat an injured person or measure whether a wound healed sooner or hurt less.
Animals receiving thymosin beta-4 had more cells move toward injuries [7]. Small blood vessels grew, fewer scars formed, and more injured cells survived. Those changes helped explain why researchers tested repair. Human healing with the smaller substance still needs evidence of its own.
Which repair findings led to TB-500 treatment claims?
A 2012 review looked mainly at animal experiments and cells maintained in dishes in a laboratory [7]. Researchers usually gave thymosin beta-4, so your response to TB-500 wasn’t tested. Cells moved toward injuries, fewer scar-forming cells appeared, and blood vessels grew. Those findings encouraged tests of eye damage, wounds, and injuries involving the brain or heart.
After injury, some blood cells release thymosin beta-4 nearby [7]. Less swelling and more surviving cells may help the damaged area mend. Yet those changes don’t establish that treatment improves your health, because an injury can look better under a microscope while pain, movement, or strength still fails to improve. You need studies showing pain relief, better movement, or other useful recovery.
Nobody has completed a human comparison testing TB-500 for these illnesses [15]. That means the evidence is missing, rather than a finished study found no help. Some studies giving the whole protein stopped early; others brought no useful improvement. Hopeful animal findings therefore leave a great deal unanswered for you.
How did the rat wounds in TB-500 claims shrink?
The rats received thymosin beta-4 on wounds, without testing healing in you [8]. Against salt-water treatment, new skin increased 42% after 4 days and up to 61% after 7 days. By day 7, the wound openings had shrunk at least 11% more. That measured wound size; the rats also made more collagen, a protein that strengthens tissue, and grew blood vessels.
The separate dish test watched skin cells move. Just 10 trillionths of a gram increased movement 2–3-fold, meaning the cells moved double or triple the earlier amount [8]. Moving cells aren’t a measure of how soon your wound closes.
What happened to mouse hearts behind TB-500 claims?
Mice received thymosin beta-4, so the test didn’t establish a heart treatment for you [9]. Researchers gave thymosin beta-4 after blocking a vessel carrying blood to the heart. More heart-muscle cells survived, heart function improved, and cells moved more within heart tissue and vessels [9]. Those results still leave human benefit from the smaller lab substance unanswered.
Did larger amounts always help stroke rats in TB-500 research?
Researchers treated stroke rats with thymosin beta-4, without testing your treatment [10]. The first belly shot came 24 hours after the stroke. Amounts were 2 or 12 milligrams per kilogram of rat weight, with each kilogram weighing just over two pounds. Another 4 shots followed, spaced 3 days apart.
The rats’ brain and nerve function improved from day 14 through day 56. Giving 18 milligrams per kilogram didn’t bring clear improvement. The test didn’t explain why the larger amount failed. Those animal amounts can’t set safe treatment for you.
Could vessels behind TB-500 claims also feed cancer?
The experiment tested thymosin beta-4 in the lab, without measuring cancer risk in you [11]. Treated cells made more of their own substance encouraging vessel growth, and cells forming vessels moved more. New vessels may bring blood to damage, yet a tumor may also gain a blood supply. That raises a concern; it hasn’t proved the smaller substance causes cancer in people [7].
Did TB-500 prove relief from swelling in people?
These tests used animals or cells kept alive in laboratory dishes. Thymosin beta-4 reduced inflammation, the swelling and soreness that often follow an injury [7]. More damaged cells survived as well [7]. Your relief from TB-500 hasn’t been established by a human treatment study.
Were human tendon injuries in TB-500 claims tested?
The review covered repair in animals given thymosin beta-4 [12]. A tendon transfers muscle pull to a bone; ligaments limit how far joints move. TB-500 hasn’t proved healing of those injuries in people. A 2026 review warned that use often goes ahead before government checks have established safety or useful treatment for patients [15].
Did new muscle cells in TB-500 research make mice stronger?
This test involved mice with muscle disease, leaving treatment of your torn muscle unknown [15]. Thymosin beta-4 belly shots gave 150 millionths of a gram; shots came twice weekly for 6 months. More muscle fibers, which are long muscle cells, began growing again. Strength and heart function didn’t improve in the mice, and scars didn’t decrease.
Sports Medicine’s 2026 review found little evidence from people to establish TB-500 safety [15]. New cells after thymosin beta-4 hadn’t helped the mice use their muscles better. You need useful strength after a muscle injury. That benefit remains unproved in people.
Which substance did volunteers in TB-500 claims receive?
There’s no completed human comparison establishing TB-500 treatment for these illnesses [15]. A Phase 1 test, an early check of safety, gave thymosin beta-4 through a vein to 40 healthy volunteers. No serious harm was reported at amounts up to 1260 milligrams [13]. Thymosin beta-4 was also tested in dry-eye drops; a planned thymosin beta-4 heart-attack trial ended before anyone joined [14].
What health problems led to TB-500 research?
Most experiments involved animals or cells living in lab dishes. Researchers examined wounds, damage to hearts and brains, new blood vessels, and hair roots [7][1]. The natural protein accounted for most of the repeated healing findings. Human evidence still leaves you without proof of which illnesses improve, and no treatment approval has been granted.
Which possible harms remain unknown for you?
Human safety evidence is thin, so your possible harms remain poorly known [7]. Several cancers contain unusually high amounts of thymosin beta-4 [7]. Researchers have linked the protein with cancer spreading and growing its blood supply. The cancer links raise concern, without establishing cancer caused by TB-500 in people.
The 2026 Sports Medicine review warned about possible serious harm when human safety tests are scarce [15]. People were using unapproved substances while those risks remained unanswered. An improved animal wound can’t establish TB-500 safety for your body. Missing studies don’t mean that possible harms are absent.
Researchers interrupted blood flow in pig hearts and then restored the flow; thymosin beta-4 didn’t reduce the damage. Stroke rats improved after 2 and 12 milligrams for each kilogram of their weight [10][15]. A kilogram weighs just over two pounds; the rats had no clear help at 18 milligrams per kilogram. Neither test established safe treatment for your illness.
Is there enough evidence to choose TB-500 or BPC-157?
Human findings are too limited to tell you which substance treats an injury safely. Sports Medicine examined TB-500 and BPC-157 in a 2026 review of unapproved treatments [15]. Common online claims about healing still lack completed human comparisons [15]. An animal’s recovery therefore leaves your own likely benefit uncertain.
TB-500 matches the thymosin beta-4 section holding the protein actin, which supports cell shape [6]. Cells can then change shape and travel toward damage. BPC-157 experiments have examined how cells survive and new blood vessels form. Different proposed actions still haven’t established which treatment helps your injury.